Serina Therapeutics
SER
37 hedge funds and large institutions have $7.27M invested in Serina Therapeutics in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 3 closing their positions.
91% more capital invested
Capital invested by funds: $3.8M → $7.27M (+$3.47M)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
3% more funds holding
Funds holding: 36 → 37 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.01% less ownership
Funds ownership: 0.37% → 0.36% (-0.01%)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$173K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$27.6K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.9K |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$5.76K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$2.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$218K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$89.7K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
-$55K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$23.6K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$20K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
27
BNP Paribas Financial Markets
Paris,
France
| $964 | -$6.34K | -110 | -86% |
|
|
RE
28
RBC Europe
London,
United Kingdom
| $866 | – | – | – |
|
|
FCH
29
Freestone Capital Holdings
Seattle,
Washington
| $760 | – | – | – |
|
|
CQS
30
Credential Qtrade Securities
Vancouver,
| $443 | +$461 | +8 | New |
|
|
WS
31
Wedbush Securities
Los Angeles,
California
| – | -$55K | -1,931 | Closed |
|
|
32
Citadel Advisors
Miami,
Florida
| – | -$20K | -696 | Closed |
|
33
Wells Fargo
San Francisco,
California
| – | +$58 | +1 | +8% |
|
|
AFG
34
Albion Financial Group
Salt Lake City,
Utah
| – | +$519 | +9 | New |
|
|
ICP
35
Interchange Capital Partners
Pittsburgh,
Pennsylvania
| – | +$634 | +11 | New |
|
SER Hedge Fund Activity: Q4 2020 in Review
37 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q4 2020, worth a combined $7.27M — up 91% from $3.8M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SER positions and 3 closed out — a net gain of 1 holder — while 7 added to existing stakes and 8 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $173K. The largest seller was Millennium Management, cutting an estimated $218K.
- 37 institutional investors held Serina Therapeutics (SER) as of Q4 2020, up from 36 in Q3 2020.
- Funds reported $7.27M of Serina Therapeutics stock for Q4 2020, up 91% quarter-over-quarter.
- 4 funds opened new Serina Therapeutics positions in Q4 2020 and 3 closed out, a net change of +1 holder.
- The largest Serina Therapeutics buyer in Q4 2020 was Renaissance Technologies, an estimated $173K added.
- The largest Serina Therapeutics seller in Q4 2020 was Millennium Management, an estimated $218K sold.
Based on aggregated 13F filings for Q4 2020.